STHLM3 Validation Study An observational study conducted in [University Medical Center Groningen and the Prostatce Cancer North Netherland Partners] in cooperation with Karolinska Institutet, Stockholm, Sweden

STHLM3 Validation Study An observational study conducted in [University Medical Center Groningen and the Prostatce Cancer North Netherland Partners] in cooperation with Karolinska Institutet, Stockholm, Sweden - STHLM3 Validation Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46757

Enrollment

100

Registered

2018-05-25

Start date

2018-06-08

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatecancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with no previous prostate cancer diagnosis who are scheduled for prostate MRI and/or prostate biopsy.

Exclusion criteria

Exclusion criteria: Patiënt with previous prostate cancer in medical history,

Design outcomes

Primary

Measure	Time frame
Main outcome * Number of biopsies	—

Secondary

Measure	Time frame
Secondary outcome * Number of biopsies with Gleason Score * 7 * Number of biopsies with Gleason Score 6 * Number of MRIs	—

Countries

Netherlands

Outcome results